Industry News
Biotechnology Industry News

Top Ginkgo execs each nab $364M pay packages thanks to 2021 SPAC deal
Top Ginkgo execs each nab $364M pay packages thanks to 2021 SPAC deal aarmstrong Wed, 03/30/2022 - 09:59
UPDATE: Top Ginkgo execs each nab $364M pay packages thanks to 2021 SPAC deal
UPDATE: Top Ginkgo execs each nab $364M pay packages thanks to 2021 SPAC deal aarmstrong Wed, 03/30/2022 - 09:59
Adagio knows its COVID-19 antibody works against old variants. Can it win EUA in the era of omicron?
Adagio knows its COVID-19 antibody works against old variants. Can it win EUA in the era of omicron? ntaylor Wed, 03/30/2022 - 08:03
Roche’s lung cancer gamble flames out as TIGIT digits come up short in phase 3
Roche's lung cancer gamble flames out as TIGIT digits come up short in phase 3 ntaylor Wed, 03/30/2022 - 05:10
Karyopharm hoping for some Keytruda stardust as former Merck & Co. exec joins as CMO
Karyopharm hoping for some Keytruda stardust as former Merck & Co. exec joins as CMO gmasson Tue, 03/29/2022 - 13:27
Outgoing NIAID vaccine R&D chief John Mascola reflects on leading ‘NASA-type incubator’
Outgoing NIAID vaccine R&D chief John Mascola reflects on leading 'NASA-type incubator' mbayer Tue, 03/29/2022 - 11:45
Cuts to the Bone: Orthopedic biotech slashes C-suite, overhauls entire pipeline
Cuts to the Bone: Orthopedic biotech slashes C-suite, overhauls entire pipeline mbayer Tue, 03/29/2022 - 10:26
Neuron23 snags $100M and a new Parkinson’s disease candidate
Neuron23 snags $100M and a new Parkinson's disease candidate ssorensen Tue, 03/29/2022 - 10:19
ImmunoGen files ovarian cancer ADC with FDA, a week after scaring investors with iffy survival data
ImmunoGen files ovarian cancer ADC with FDA, a week after scaring investors with iffy survival data aarmstrong Tue, 03/29/2022 - 09:34
Pfizer’s $7B ulcerative colitis drug racks up another phase 3 win, laying the groundwork for approval filings
Pfizer's $7B ulcerative colitis drug racks up another phase 3 win, laying the groundwork for approval filings ntaylor Tue, 03/29/2022 - 08:08
Sanofi pulls IGM into dealmaking whirlwind, paying $150M upfront to form 6-target R&D pact
Sanofi pulls IGM into dealmaking whirlwind, paying $150M upfront to form 6-target R&D pact ntaylor Tue, 03/29/2022 - 05:58
Biden seeks $2.1B funding boost for FDA, part of pan-agency pandemic preparedness plan
Biden seeks $2.1B funding boost for FDA, part of pan-agency pandemic preparedness plan aarmstrong Mon, 03/28/2022 - 14:26
Amylyx to answer for single-study ALS application at FDA advisory panel
Amylyx to answer for single-study ALS application at FDA advisory panel aarmstrong Mon, 03/28/2022 - 10:47
Another Biogen-Ionis collab hits the dust after phase 1 ALS flop
Another Biogen-Ionis collab hits the dust after phase 1 ALS flop mbayer Mon, 03/28/2022 - 10:38
Verastem takes on debt to get RAS tumor program to finish line
Verastem takes on debt to get RAS tumor program to finish line ntaylor Mon, 03/28/2022 - 08:17
Lilly, after making $1B bet, posts ‘compelling’ late-phase data on Dupixent rival
Lilly, after making $1B bet, posts 'compelling' late-phase data on Dupixent rival ntaylor Mon, 03/28/2022 - 06:12
Icosavax’s COVID-19 shot fails to deliver in early data, spurring debate about ‘fatal flaw’ in platform
Icosavax's COVID-19 shot fails to deliver in early data, spurring debate about 'fatal flaw' in platform mbayer Fri, 03/25/2022 - 10:18
89bio gains a little more confidence in NASH treatment with new hormone data
89bio gains a little more confidence in NASH treatment with new hormone data aarmstrong Fri, 03/25/2022 - 09:54
AN2 upsizes IPO, teeing up bid to revitalize antibiotic let go by GSK and Pfizer
AN2 upsizes IPO, teeing up bid to revitalize antibiotic let go by GSK and Pfizer ntaylor Fri, 03/25/2022 - 07:50
MEI rocked as FDA request for randomized data on cancer drug ends hopes of accelerated approval
MEI rocked as FDA request for randomized data on cancer drug ends hopes of accelerated approval ntaylor Fri, 03/25/2022 - 05:26

